Cumberland Pharmaceuticals Inc.

CPIX

$6.80

+0.74%

2026-09-04 11:40:00 EDT+$0.05

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic ...

Financial Highlights of CPIX

Profitability trend

Latest / TTM · 6 periods

Gross Margin

83.4%

Net Margin

-33.9%

P/E Ratio

-9.48x

n/a

Debt / Equity

0.27

n/a

Current Ratio

0.96

Dividend Yield

22.2%

Understanding

TTM —

Current ratio below 1.0

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

83.4%

Net Margin

-33.9%

P/E Ratio

-9.48x

Debt / Equity

0.27

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	75.5%	78.3%	84.7%	82.6%	85.0%	—
Operating MarginOperating income as a percentage of revenue.	-21.3%	-13.6%	-24.2%	-17.0%	-6.3%	—
Net MarginNet income as a percentage of revenue.	-9.7%	-13.3%	-15.9%	-17.1%	-6.4%	—
EBITDA MarginEBITDA divided by revenue.	-2.4%	0.8%	6.3%	0.5%	6.6%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-15.5%	-13.3%	-15.9%	-17.1%	-6.3%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	2.37	1.60	1.28	1.15	1.01	—
Quick RatioLiquid assets divided by current liabilities.	1.93	1.26	1.11	1.03	0.84	—
Cash RatioCash and equivalents divided by current liabilities.	1.40	0.69	0.65	0.57	0.31	—
Debt / AssetsDebt as a share of total assets.	19.0%	22.6%	22.5%	27.2%	13.3%	—
Debt / EquityDebt compared with shareholder equity.	0.38	0.58	0.62	0.90	0.41	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	5.23x	3.19x	4.05x	3.24x	2.63x	—
Inventory TurnoverHow often inventory is sold in a year.	1.05x	0.92x	1.32x	1.65x	1.07x	—
Payables TurnoverHow often payables are paid in a year.	0.91x	0.84x	0.43x	0.47x	0.36x	—
Asset TurnoverRevenue generated per dollar of assets.	0.43x	0.45x	0.48x	0.50x	0.58x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	1.42x	1.92x	3.16x	6.03x	17.30x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-19.46x	-5.92x	-4.07x	-5.15x	-20.95x	—
P/B RatioPrice paid for each dollar of book value.	1.63x	0.90x	0.86x	1.46x	2.39x	—
P/S RatioPrice paid for each dollar of sales.	1.93x	0.78x	0.65x	0.88x	1.34x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	11.62x	5.14x	4.54x	-42.08x	12.31x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

Supply Chain of CPIX

RELATIONS

Upstream

Nephron Pharmaceuticals CorporationBioniche TeorantaBayer AGXETRA:BAYNKyowa Kirin Co., Ltd.TSE:4151Univar Solutions Inc.NYSE:UNVR

Downstream

Cardinal Health Inc.NYSE:CAHVerity PharmaceuticalsPiramal Pharma Limited (Piramal Critical Care)NSE:PPLPHARMARedHill Biopharma Ltd.NASDAQ:RDHLSciClone Pharmaceuticals (Holdings) LimitedWinHealth Pharma Group Co. LimitedPiSA FarmaceuticaTabuk Pharmaceutical Manufacturing CompanyDB Pharm Korea Co. Ltd.Phebra Pty Ltd.Apotex Health Corp.TSX:APTX

Proxies

RedHill Biopharma Ltd.NASDAQ:RDHLSciClone Pharmaceuticals (Holdings) LimitedUnconfirmedApotex Health Corp.TSX:APTXCardinal Health Inc.NYSE:CAHKyowa Kirin Co., Ltd.TSE:4151

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer